Close Menu
  • Home
  • Business News
    • Entrepreneurship
  • Investments
  • Markets
  • Opinion
  • Politics
  • Startups
    • Stock Market
  • Trending
    • Technology
  • Online Jobs

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

What's Hot

Tech Entrepreneurship: Eliminating waste and eliminating scarcity

July 17, 2024

AI for Entrepreneurs and Small Business Owners

July 17, 2024

Young Entrepreneurs Succeed in Timor-Leste Business Plan Competition

July 17, 2024
Facebook X (Twitter) Instagram
  • Home
  • Business News
    • Entrepreneurship
  • Investments
  • Markets
  • Opinion
  • Politics
  • Startups
    • Stock Market
  • Trending
    • Technology
  • Online Jobs
Facebook X (Twitter) Instagram Pinterest
Prosper planet pulse
  • Home
  • Privacy Policy
  • About us
    • Advertise with Us
  • AFFILIATE DISCLOSURE
  • Contact
  • DMCA Policy
  • Our Authors
  • Terms of Use
  • Shop
Prosper planet pulse
Home»Opinion»OPINION | Supreme Court Mifepristone Decision and Retracted Study
Opinion

OPINION | Supreme Court Mifepristone Decision and Retracted Study

prosperplanetpulse.comBy prosperplanetpulse.comJune 10, 2024No Comments4 Mins Read0 Views
Share Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


Caitlin Jeterina is an epidemiologist and author of the Substack newsletter. Your local epidemiologist, A version of this column originally appeared here. Heidi Mosesson is an epidemiologist at Ibis Reproductive Health.

In March, the Supreme Court heard a case about access to mifepristone, one of the two drugs used in medication abortion. But just weeks before, a scientific controversy roiled the debate: Some of the scientific studies that were the basis of a legal challenge to the abortion drug were retracted by the academic publishing company Sage due to methodological and ethical concerns. The Supreme Court is expected to rule within the next few days or weeks.

This is a big problem. Published papers are not removed from scientific journals because of minor mistakes. Papers are retracted rarely (around 1 in 500), but the rate is increasing, and the majority of these are due to misconduct. Retractions are decided by the authors (when they realize a major mistake) or by the publisher (for fraud, plagiarism, ethics, etc.).

The lawsuit was filed after anti-abortion doctors alleged that the Food and Drug Administration had ignored safety concerns when it relaxed restrictions on access to mifepristone. They based their case on a scientific study that cited the number of emergency room visits following mifepristone use to argue that the drug is dangerous. However, after the study was published, other scientists raised serious concerns about the statistical methodology and questioned the conclusions.

For example, outside groups found that one of the retracted studies used inaccurate medical codes (numbers used to interpret medical procedures and diagnoses) to count “abortion-related” emergency room visits. The study used a code for an ectopic pregnancy, which occurs naturally and is unrelated to abortion.

The findings were also presented in other deceptive ways, such as charts and graphs containing double Y-axes (two scales on the same chart). Below is a screenshot of the chart as it was originally published:


Emergency department visits within the first 30 days

Abortion

Source: Studnicki et al., 2021

Emergency department visits within the first 30 days

Abortion

Source: Studnicki et al., 2021

Visiting an emergency department within 30 days of the abortion

Source: Studnicki et al., 2021

However, when the y-axis is properly displayed on a single scale, abortions contribute significantly less to emergency room visits. Here’s the graph at the correct scale:


Emergency department visits within the first 30 days

Abortion

Source: Upadhyay and Adkins, 2024

Emergency department visits within the first 30 days

Abortion

Source: Upadhyay and Adkins, 2024

Visiting an emergency department within 30 days of the abortion

Source: Upadhyay and Adkins, 2024

After these concerns were raised, Sage commissioned two subject matter experts and one independent statistical analyst to peer review the studies (which were published in 2019, 2021, and 2022). Sage did not make the results of the expert reviews public, as is standard practice, but given the importance of this case, they may be made public.

Experts identified significant ethical issues and scientific errors, including that reviewers knew at least one of the authors of the three studies, and that several are members of the same pro-life advocacy group, despite the studies declaring no conflicts of interest. The Sage investigation also concluded that there were “unjustified or erroneous factual assumptions,” “significant errors,” and “misleading presentations” of the data that “demonstrate a lack of scientific rigor and invalidate the authors’ conclusions in whole or in part.”

Clinical guidance and policies are (ideally) built on decades of research and consideration of the entire evidence. In the case of mifepristone, over 100 studies have shown it to be safe; in fact, it is safer than Tylenol. There are only a few contradictory studies. However, big mistakes can get through the peer review process, and in rare cases the “mistakes” are intentional and egregious. Even if the studies are retracted, they can do great harm. (See Wakefield’s study on autism and the measles, mumps, rubella vaccine.)

We all deserve a strong data foundation to make smart medical decisions. This data foundation relies heavily on ethical scientists and a strong review process. Retracted studies should never end up in the Supreme Court.



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
prosperplanetpulse.com
  • Website

Related Posts

Opinion

The rule of law is more important than feelings about Trump | Opinion

July 15, 2024
Opinion

OPINION | Biden needs to follow through on promise to help Tulsa victims

July 15, 2024
Opinion

Opinion | Why China is off-limits to me now

July 15, 2024
Opinion

Opinion | Fast food chains’ value menu wars benefit consumers

July 15, 2024
Opinion

Uncovering the truth about IVF myths | Opinion

July 15, 2024
Opinion

Opinion: America’s definition of “refugee” needs updating

July 15, 2024
Add A Comment
Leave A Reply Cancel Reply

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Editor's Picks

The rule of law is more important than feelings about Trump | Opinion

July 15, 2024

OPINION | Biden needs to follow through on promise to help Tulsa victims

July 15, 2024

Opinion | Why China is off-limits to me now

July 15, 2024

Opinion | Fast food chains’ value menu wars benefit consumers

July 15, 2024
Latest Posts

ATLANTIC-ACM Announces 2024 U.S. Business Connectivity Service Provider Excellence Awards

July 10, 2024

Costco’s hourly workers will get a pay raise. Read the CEO memo.

July 10, 2024

Why a Rockland restaurant closed after 48 years

July 10, 2024

Stay Connected

Twitter Linkedin-in Instagram Facebook-f Youtube

Subscribe